ZA200708600B - Novel liposome compositions - Google Patents
Novel liposome compositionsInfo
- Publication number
- ZA200708600B ZA200708600B ZA200708600A ZA200708600A ZA200708600B ZA 200708600 B ZA200708600 B ZA 200708600B ZA 200708600 A ZA200708600 A ZA 200708600A ZA 200708600 A ZA200708600 A ZA 200708600A ZA 200708600 B ZA200708600 B ZA 200708600B
- Authority
- ZA
- South Africa
- Prior art keywords
- liposome compositions
- novel liposome
- novel
- compositions
- liposome
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005067469A JP2006248978A (ja) | 2005-03-10 | 2005-03-10 | 新規なリポソーム製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200708600B true ZA200708600B (en) | 2009-01-28 |
Family
ID=36992280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200708600A ZA200708600B (en) | 2005-03-10 | 2006-03-08 | Novel liposome compositions |
Country Status (22)
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101223366B1 (ko) | 2004-05-03 | 2013-01-16 | 헤르메스 바이오사이언스, 인코포레이티드 | 약물 전달에 유용한 리포좀 |
JP2006248978A (ja) | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | 新規なリポソーム製剤 |
CN101209243B (zh) * | 2006-12-29 | 2010-12-08 | 石药集团中奇制药技术(石家庄)有限公司 | 一种脂质体药物及其制备方法 |
ES2550759T3 (es) * | 2007-08-17 | 2015-11-12 | Celator Pharmaceuticals, Inc. | Formulaciones farmacológicas de platino mejoradas |
EP2190429B1 (en) * | 2007-09-10 | 2016-04-20 | Boston Biomedical, Inc. | A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors |
TWI468188B (zh) | 2008-01-30 | 2015-01-11 | Univ Tokushima | Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation |
US9849173B2 (en) * | 2009-07-06 | 2017-12-26 | Variation Biotechnologies Inc. | Methods for preparing vesicles and formulations produced therefrom |
US8956600B2 (en) | 2009-08-10 | 2015-02-17 | Taiwan Liposome Co. Ltd. | Ophthalmic drug delivery system containing phospholipid and cholesterol |
WO2011038068A1 (en) * | 2009-09-23 | 2011-03-31 | Formatech, Inc. | Methods for the preparation of liposomes |
US10143652B2 (en) * | 2009-09-23 | 2018-12-04 | Curirx Inc. | Methods for the preparation of liposomes |
WO2011102904A1 (en) * | 2010-02-19 | 2011-08-25 | Robert Shorr | Imageable lipid-oil-water nanoemulsion therapeutic delivery system |
AU2011227023B2 (en) | 2010-03-19 | 2015-05-28 | Boston Biomedical, Inc. | Novel methods for targeting cancer stem cells |
US9492480B2 (en) * | 2010-04-12 | 2016-11-15 | Ramot At Tel Aviv University Ltd. | Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders |
KR101908445B1 (ko) | 2010-11-12 | 2018-10-17 | 코어 파마슈티칼스 디벨롭먼트 컴퍼니 인크. | 변형된 면역-조절 입자 |
WO2012153616A1 (ja) * | 2011-05-10 | 2012-11-15 | 国立大学法人北海道大学 | 標的細胞移行能を有する脂質膜構造体、その製造方法および標的細胞において効果を示す物質のスクリーニング方法 |
JP5983608B2 (ja) * | 2011-07-15 | 2016-09-06 | コニカミノルタ株式会社 | 溶解助剤を利用したリポソーム含有製剤およびその製造方法 |
WO2013066438A2 (en) | 2011-07-22 | 2013-05-10 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
JP2015509085A (ja) * | 2012-01-01 | 2015-03-26 | キュービーアイ エンタープライゼズ リミテッドQbi Enterprises Ltd. | 治療剤および診断剤の選択的送達のためのendo180を標的とする粒子 |
AU2013202947B2 (en) | 2012-06-13 | 2016-06-02 | Ipsen Biopharm Ltd. | Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan |
US9717724B2 (en) | 2012-06-13 | 2017-08-01 | Ipsen Biopharm Ltd. | Methods for treating pancreatic cancer using combination therapies |
RU2669346C2 (ru) | 2012-06-21 | 2018-10-10 | Норсвестерн Юниверсити | Частицы, конъюгированные с пептидами |
JP6230538B2 (ja) * | 2012-08-10 | 2017-11-15 | 大鵬薬品工業株式会社 | 安定なオキサリプラチン封入リポソーム水分散液及びその安定化方法 |
US10188728B2 (en) | 2012-12-12 | 2019-01-29 | Temple University—Of the Commonwealth System of Higher Education | Compositions and methods for treatment of cancer |
CN103083239B (zh) * | 2012-12-26 | 2015-11-25 | 中国人民解放军第四军医大学 | 一种蟾毒灵脂质体及其制备方法和应用 |
TW201427681A (zh) | 2013-01-07 | 2014-07-16 | Superlab Far East Ltd | 用空間構象改變的重組干擾素治療腫瘤的方法 |
US9468681B2 (en) | 2013-03-01 | 2016-10-18 | California Institute Of Technology | Targeted nanoparticles |
IL292823B2 (en) | 2013-03-13 | 2023-11-01 | Cour Pharmaceuticals Dev Company | Secondary vaccine particles for the treatment of inflammation |
BR112015022415A2 (pt) * | 2013-03-13 | 2017-07-18 | Mallinckrodt Llc | composições de cisplatina lipossômica para terapia contra câncer |
BR112015022476A2 (pt) * | 2013-03-13 | 2017-07-18 | Mallinckrodt Llc | composições de oxaliplatina de lipossoma para terapia de câncer |
BR112015025347A2 (pt) | 2013-04-09 | 2017-07-18 | Boston Biomedical Inc | 2-acetil-nafto [2-3-b] furan-4,9-diona para uso no tratamento do câncer |
US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
DK3033102T4 (da) | 2013-08-13 | 2024-02-26 | Univ Northwestern | Peptidkonjugerede partikler |
US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US9228207B2 (en) | 2013-09-06 | 2016-01-05 | President And Fellows Of Harvard College | Switchable gRNAs comprising aptamers |
US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
WO2016070129A1 (en) | 2014-10-30 | 2016-05-06 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
LT3066201T (lt) | 2013-11-07 | 2018-08-10 | Editas Medicine, Inc. | Su crispr susiję būdai ir kompozicijos su valdančiomis grnr |
US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
WO2015183357A2 (en) * | 2014-02-21 | 2015-12-03 | The Curators Of The University Of Missouri | Compositions and methods for boron neutron capture therapy |
US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US10098813B2 (en) * | 2014-09-03 | 2018-10-16 | Sun Pharmaceutical Industries Limited | Perfusion dosage form |
US9816080B2 (en) | 2014-10-31 | 2017-11-14 | President And Fellows Of Harvard College | Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs) |
US11318131B2 (en) | 2015-05-18 | 2022-05-03 | Ipsen Biopharm Ltd. | Nanoliposomal irinotecan for use in treating small cell lung cancer |
US10988496B2 (en) | 2015-06-24 | 2021-04-27 | Nippon Kayaku Kabushiki Kaisha | Platinum (IV) complex |
WO2017031442A1 (en) | 2015-08-20 | 2017-02-23 | Merrimack Pharmaceuticals, Inc. | Combination therapy using liposomal irinotecan and a parp inhibitor for cancer treatment |
CA2993451A1 (en) | 2015-08-21 | 2017-03-02 | Ipsen Biopharm Ltd. | Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin |
EP3351580B1 (en) | 2015-09-14 | 2021-02-24 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of hexa-coordinated platinum complex |
BR122021024957B1 (pt) | 2015-10-16 | 2023-12-12 | Ipsen Biopharm Ltd | Processos de produção de uma composição de irinotecano lipossômico estabilizado em armazenamento |
EP3365357B1 (en) | 2015-10-23 | 2024-02-14 | President and Fellows of Harvard College | Evolved cas9 proteins for gene editing |
US20180318216A1 (en) * | 2015-11-20 | 2018-11-08 | The Regents Of The University Of California | Deformable nano-scale vehicles (dnvs) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery |
JP6831796B2 (ja) | 2015-12-22 | 2021-02-17 | 日本化薬株式会社 | スルホキシド誘導体配位白金(ii)錯体の高分子結合体 |
CN109678910B (zh) | 2016-01-25 | 2021-09-07 | 沈阳药科大学 | 一种化合物及其应用以及一种铂类配合物及其脂质体 |
JP2019512489A (ja) * | 2016-03-07 | 2019-05-16 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | マイクロrnaおよびその使用方法 |
JP6606600B2 (ja) * | 2016-04-15 | 2019-11-13 | 富士フイルム株式会社 | マイクロニードルアレイ |
CN109562067A (zh) * | 2016-08-02 | 2019-04-02 | 库里尔克思股份有限公司 | 制备脂质体的方法 |
AU2017306676B2 (en) | 2016-08-03 | 2024-02-22 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
AU2017308889B2 (en) | 2016-08-09 | 2023-11-09 | President And Fellows Of Harvard College | Programmable Cas9-recombinase fusion proteins and uses thereof |
CA3033083A1 (en) | 2016-08-12 | 2018-02-15 | L.E.A.F. Holdings Group Llc | Polyglutamated antifolates and uses thereof |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
SG11201903089RA (en) | 2016-10-14 | 2019-05-30 | Harvard College | Aav delivery of nucleobase editors |
US11071726B2 (en) | 2016-11-02 | 2021-07-27 | Ipsen Biopharm Ltd. | Treating gastric cancer using combination therapies comprising liposomal irinotecan, oxaliplatin, 5-fluorouracil (and leucovorin) |
CN109996809A (zh) | 2016-11-14 | 2019-07-09 | 诺华股份有限公司 | 与促融合蛋白minion相关的组合物、方法和治疗用途 |
JP7106563B2 (ja) | 2016-11-29 | 2022-07-26 | スミトモ ファーマ オンコロジー, インコーポレイテッド | ナフトフラン誘導体、その調製、および使用方法 |
WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
WO2018165504A1 (en) | 2017-03-09 | 2018-09-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
IL306092A (en) | 2017-03-23 | 2023-11-01 | Harvard College | Nucleic base editors that include nucleic acid programmable DNA binding proteins |
EP3634385A4 (en) * | 2017-05-12 | 2021-03-03 | Curinanorx, LLC | LIPOSOME PREPARATION PROCESSES INCLUDING MEDICINAL PRODUCTS |
WO2018209320A1 (en) | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation |
US10646464B2 (en) | 2017-05-17 | 2020-05-12 | Boston Biomedical, Inc. | Methods for treating cancer |
JP2020534795A (ja) | 2017-07-28 | 2020-12-03 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ファージによって支援される連続的進化(pace)を用いて塩基編集因子を進化させるための方法および組成物 |
WO2019139645A2 (en) | 2017-08-30 | 2019-07-18 | President And Fellows Of Harvard College | High efficiency base editors comprising gam |
US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
EP3749317A4 (en) | 2018-02-07 | 2022-06-22 | L.E.A.F Holdings Group LLC | PEMETREXED ALPHA-POLYGLUTAMATE AND ASSOCIATED USES |
CA3090387A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated pralatrexate and uses thereof |
US11771700B2 (en) | 2018-02-14 | 2023-10-03 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated lometrexol and uses thereof |
CN108524450A (zh) * | 2018-04-16 | 2018-09-14 | 温州医科大学 | 基于磁性热敏阳离子脂质体的奥沙利铂和mdc1-as共传递药物载体的制备及应用 |
EP3856226A1 (en) | 2018-09-28 | 2021-08-04 | President and Fellows of Harvard College | Cellular reprogramming to reverse aging and promote organ and tissue regeneration |
EP3864163B1 (en) | 2018-10-09 | 2024-03-20 | The University of British Columbia | Compositions and systems comprising transfection-competent vesicles free of organic-solvents and detergents and methods related thereto |
CN111721841B (zh) * | 2019-03-19 | 2022-07-12 | 海南长安国际制药有限公司 | 与洛铂有关物质的检测 |
JP2022526908A (ja) | 2019-03-19 | 2022-05-27 | ザ ブロード インスティテュート,インコーポレーテッド | 編集ヌクレオチド配列を編集するための方法および組成物 |
CN110292563B (zh) * | 2019-06-12 | 2021-07-16 | 兰州大学 | 基于叶酸热敏脂质体的阴离子载体诱导癌细胞凋亡的方法 |
CN116096890A (zh) | 2020-04-02 | 2023-05-09 | 米雷楚莱股份有限公司 | 使用工程化寡核苷酸的靶向抑制 |
AU2021267940A1 (en) | 2020-05-08 | 2022-12-08 | President And Fellows Of Harvard College | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
CN112129871B (zh) * | 2020-09-04 | 2021-06-15 | 斯微(上海)生物科技有限公司 | 复合磷脂脂质体中dope和m5两种磷脂含量的检测方法 |
CN112870164B (zh) * | 2021-01-25 | 2021-12-17 | 山东大学 | 一种双靶向载药脂质体及其制备方法和应用 |
WO2023196851A1 (en) | 2022-04-06 | 2023-10-12 | President And Fellows Of Harvard College | Reversing aging of the central nervous system |
Family Cites Families (159)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6041077B2 (ja) | 1976-09-06 | 1985-09-13 | 喜徳 喜谷 | 1,2‐ジアミノシクロヘキサン異性体のシス白金(2)錯体 |
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
GR75598B (US07829113-20101109-C00009.png) | 1980-04-29 | 1984-08-01 | Sanofi Sa | |
US4534899A (en) | 1981-07-20 | 1985-08-13 | Lipid Specialties, Inc. | Synthetic phospholipid compounds |
US4565696A (en) | 1983-08-03 | 1986-01-21 | The Regents Of The University Of California | Production of immunogens by antigen conjugation to liposomes |
US4789633A (en) | 1984-04-19 | 1988-12-06 | University Of Tennessee Research Corporation | Fused liposome and acid induced method for liposome fusion |
US4925661A (en) | 1984-04-19 | 1990-05-15 | Leaf Huang | Target-specific cytotoxic liposomes |
US5736155A (en) | 1984-08-08 | 1998-04-07 | The Liposome Company, Inc. | Encapsulation of antineoplastic agents in liposomes |
US4762915A (en) * | 1985-01-18 | 1988-08-09 | Liposome Technology, Inc. | Protein-liposome conjugates |
WO1986004232A1 (en) * | 1985-01-18 | 1986-07-31 | Cooper-Lipotech, Inc. | Liposome composition and method |
US5026651A (en) | 1985-04-25 | 1991-06-25 | Board Of Regents, The University Of Texas System | Methods and compositions for the production of human transferrin |
PH26160A (en) * | 1985-08-19 | 1992-03-18 | Univ Texas | Pharmaceutical compositions consisting of acylated phospholipids |
US4983397A (en) | 1985-08-19 | 1991-01-08 | Board Of Regents, University Of Texas System | Pharmaceutical compositions consisting of acylated phospholipids |
US5384127A (en) | 1985-10-18 | 1995-01-24 | Board Of Regents, The University Of Texas System | Stable liposomal formulations of lipophilic platinum compounds |
JPH0714865B2 (ja) | 1986-10-28 | 1995-02-22 | 武田薬品工業株式会社 | リポソ−ム製剤およびその製造法 |
US5049390A (en) | 1987-09-02 | 1991-09-17 | Allergy Immuno Technologies, Inc. | Liposome containing immunotherapy agents for treating IgE mediated allergies |
US4853224A (en) | 1987-12-22 | 1989-08-01 | Visionex | Biodegradable ocular implants |
FR2631826B1 (fr) | 1988-05-27 | 1992-06-19 | Centre Nat Rech Scient | Vecteur particulaire utile notamment pour le transport de molecules a activite biologique et procede pour sa preparation |
JPH0720857B2 (ja) | 1988-08-11 | 1995-03-08 | テルモ株式会社 | リポソームおよびその製法 |
DK0436717T3 (da) | 1989-08-02 | 2003-05-05 | Mitra Medical Technology Ab | System til anvendelse ved en fremgangsmåde til terapeutisk eller diagnostisk behandling |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
DK0555317T3 (da) * | 1990-10-09 | 1995-08-07 | Nexstar Pharmaceuticals Inc | Phospholipid-analog-vesikel med en succinimidylsubstituent |
US5554728A (en) | 1991-07-23 | 1996-09-10 | Nexstar Pharmaceuticals, Inc. | Lipid conjugates of therapeutic peptides and protease inhibitors |
US6509032B1 (en) | 1991-08-28 | 2003-01-21 | Mcmaster University | Cationic amphiphiles |
US5292524A (en) | 1991-09-06 | 1994-03-08 | California Institute Of Technology | Blood platelet loaded with diagnostic or therapeutic-containing liposome or reconstituted Sendai virus |
JPH0776230B2 (ja) | 1992-01-13 | 1995-08-16 | 田中貴金属工業株式会社 | 白金化合物の製造方法 |
JP2673331B2 (ja) | 1993-01-12 | 1997-11-05 | 田中貴金属工業 株式会社 | 光学的に高純度なシス―オキザラート(トランス―1―1,2―シクロヘキサンジアミン)白金(▲ii▼) |
JPH06287021A (ja) | 1992-04-22 | 1994-10-11 | Tanaka Kikinzoku Kogyo Kk | 光学活性な白金錯化合物の光学的分割方法 |
US20030190638A1 (en) | 1992-05-13 | 2003-10-09 | Board Of Regents, The University Of Texas System | Methods of screening for compounds that derepress or increase telomerase activity |
US5962316A (en) | 1992-10-16 | 1999-10-05 | Cold Spring Harbor Laboratory | Cell-cycle regulatory proteins, and uses related thereto |
US20030100489A1 (en) | 1992-10-16 | 2003-05-29 | Beach David H. | Cell-cycle regulatory proteins, and uses related thereto |
WO1994026254A1 (en) | 1993-05-17 | 1994-11-24 | The Liposome Company, Inc. | Incorporation of taxol into liposomes and gels |
JP3025602B2 (ja) | 1993-05-21 | 2000-03-27 | デビオファーム エス.アー. | 光学的に高純度なシス−オキザラート(トランス−l−1,2−シクロヘキサンジアミン)白金(II)錯体の製造方法 |
US5534241A (en) | 1993-07-23 | 1996-07-09 | Torchilin; Vladimir P. | Amphipathic polychelating compounds and methods of use |
ATE222752T1 (de) * | 1993-10-06 | 2002-09-15 | Amgen Inc | Stabile protein-phospholipid zusammensetzungen und verfahren |
WO1995016774A1 (en) | 1993-12-17 | 1995-06-22 | Spinal Cord Society | Method for inducing dna synthesis in neurons |
US5830686A (en) | 1994-01-13 | 1998-11-03 | Calydon | Tissue-specific enhancer active in prostate |
US6057299A (en) | 1994-01-13 | 2000-05-02 | Calydon, Inc. | Tissue-specific enhancer active in prostate |
JP3590983B2 (ja) * | 1994-03-04 | 2004-11-17 | 日本油脂株式会社 | リン脂質誘導体 |
ZA952485B (en) | 1994-03-28 | 1995-12-15 | Nycomed Imaging As | Liposomes |
CA2192836A1 (en) | 1994-07-29 | 1996-02-15 | Anthony R. Haight | Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane |
IL114852A (en) | 1994-08-08 | 2000-02-29 | Debiopharm Sa | Pharmaceutically stable preparation of oxaliplatinum |
KR100381449B1 (ko) * | 1994-10-14 | 2003-07-18 | 더 리포좀 컴퍼니, 인코퍼레이티드 | 에테르지질리포좀과이들의제약학적용도 |
EP0715854B1 (en) | 1994-11-11 | 2003-09-10 | Debiopharm S.A. | Carcinostatic compositions containing cis-oxaliplatinum and one or more other compatible carcinostatic substances |
US5786214A (en) | 1994-12-15 | 1998-07-28 | Spinal Cord Society | pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system |
US5580899A (en) * | 1995-01-09 | 1996-12-03 | The Liposome Company, Inc. | Hydrophobic taxane derivatives |
US6008202A (en) | 1995-01-23 | 1999-12-28 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
TW319763B (US07829113-20101109-C00009.png) | 1995-02-01 | 1997-11-11 | Epix Medical Inc | |
US5780052A (en) | 1995-04-24 | 1998-07-14 | Northeastern University | Compositions and methods useful for inhibiting cell death and for delivering an agent into a cell |
US5834012A (en) * | 1995-05-03 | 1998-11-10 | Roman Perez-Soler | Lipid complexed topoisomerase I inhibitors |
US20020022264A1 (en) | 1995-05-26 | 2002-02-21 | Sullivan Sean M. | Delivery vehicles comprising stable lipid/nucleic acid complexes |
US6825174B2 (en) | 1995-06-07 | 2004-11-30 | East Carolina University | Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation |
JPH09278785A (ja) | 1996-04-10 | 1997-10-28 | Tanaka Kikinzoku Kogyo Kk | 白金化合物の製造方法 |
FR2740686B1 (fr) | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
US6428977B1 (en) | 1995-12-20 | 2002-08-06 | Curis, Inc. | Signalin family of TGFβ signal transduction proteins, and uses related thereto |
JP3735921B2 (ja) | 1996-02-07 | 2006-01-18 | 三菱ウェルファーマ株式会社 | GPIb・脂質複合体およびその用途 |
US6077834A (en) | 1996-02-09 | 2000-06-20 | Cheng; Pi-Wan | Receptor ligand-facilitated delivery of biologically active molecules |
DE69713763T2 (de) | 1996-03-11 | 2003-03-13 | Yoshinori Kidani | Binukleare platinkomplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese komplexe enthalten |
EP0914094A4 (en) | 1996-03-28 | 2000-03-01 | Univ Illinois | MATERIALS AND METHOD FOR PRODUCING IMPROVED LIPOSOMAL AGENTS |
JP3154399B2 (ja) | 1996-07-04 | 2001-04-09 | デビオファーム エス.アー. | 白金化合物の製造方法 |
WO1997042166A1 (fr) | 1996-05-02 | 1997-11-13 | Terumo Kabushiki Kaisha | Derives amidines et vecteurs de medicaments les contenant |
AU714992B2 (en) | 1996-08-23 | 2000-01-13 | Alza Corporation | Liposomes containing a cisplatin compound |
TW520297B (en) * | 1996-10-11 | 2003-02-11 | Sequus Pharm Inc | Fusogenic liposome composition and method |
US6056973A (en) * | 1996-10-11 | 2000-05-02 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method of preparation |
NZ514133A (en) | 1996-10-15 | 2001-09-28 | Liposome Co Inc | N-acyl phosphatidylethanolamine-mediated liposomal drug delivery |
DE69723473T2 (de) * | 1996-10-15 | 2004-05-27 | The Liposome Co., Inc. | Peptid-lipid konjugate, liposomen und liposomale arzneimittelverabreichung |
WO1998027209A1 (en) | 1996-12-18 | 1998-06-25 | Emory University | Polycationic oligomers |
JP2001513110A (ja) | 1997-03-07 | 2001-08-28 | サノフィ−シンテラボ インコーポレイティド | 腫瘍治療方法 |
DE19709704C2 (de) | 1997-03-10 | 1999-11-04 | Michael Georgieff | Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie |
JPH10253632A (ja) | 1997-03-10 | 1998-09-25 | Nissui Pharm Co Ltd | 分析方法、キット及び装置 |
US6120751A (en) * | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
US6060082A (en) | 1997-04-18 | 2000-05-09 | Massachusetts Institute Of Technology | Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery |
US6524613B1 (en) | 1997-04-30 | 2003-02-25 | Regents Of The University Of Minnesota | Hepatocellular chimeraplasty |
US6272370B1 (en) | 1998-08-07 | 2001-08-07 | The Regents Of University Of Minnesota | MR-visible medical device for neurological interventions using nonlinear magnetic stereotaxis and a method imaging |
WO1998059035A2 (en) | 1997-06-25 | 1998-12-30 | The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health | Serum-free cell growth medium |
WO1999003889A1 (en) | 1997-07-15 | 1999-01-28 | The Regents Of The University Of California | Isolated dna encoding human calcium activated potassium channel |
DE69838584T2 (de) | 1997-08-04 | 2008-06-26 | Cell Genesys, Inc., Foster City | Enhancer des menschlichen glandulären kallikreingens, vektoren die ihn enthalten und methoden für seine verwendung |
NZ503402A (en) | 1997-10-02 | 2002-03-01 | Epix Medical Inc | Contrast-enhanced diagnostic imaging method for monitoring interventional therapies |
US6749863B1 (en) | 1997-11-19 | 2004-06-15 | Georgetown University | Targeted liposome gene delivery |
US6320017B1 (en) | 1997-12-23 | 2001-11-20 | Inex Pharmaceuticals Corp. | Polyamide oligomers |
AU2669599A (en) | 1998-02-12 | 1999-08-30 | Regents Of The University Of California, The | Compositions for receptor/liposome mediated transfection and methods of using same |
GB9804013D0 (en) | 1998-02-25 | 1998-04-22 | Sanofi Sa | Formulations |
US6245427B1 (en) | 1998-07-06 | 2001-06-12 | DüZGüNES NEJAT | Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles |
AU762138B2 (en) | 1998-10-14 | 2003-06-19 | Debiopharm S.A. | Oxaliplatinum preparation packaging |
US7311924B2 (en) | 1999-04-01 | 2007-12-25 | Hana Biosciences, Inc. | Compositions and methods for treating cancer |
US6723338B1 (en) | 1999-04-01 | 2004-04-20 | Inex Pharmaceuticals Corporation | Compositions and methods for treating lymphoma |
WO2000069915A2 (en) | 1999-05-17 | 2000-11-23 | Avi Biopharma, Inc. | COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES |
JP2001002592A (ja) | 1999-06-18 | 2001-01-09 | Dai Ichi Seiyaku Co Ltd | 遺伝子導入用組成物 |
US6280054B1 (en) * | 1999-07-02 | 2001-08-28 | Zight Corporation | Image generator having an improved illumination system |
US6242188B1 (en) | 1999-07-30 | 2001-06-05 | Applied Gene Technologies, Inc. | Sample processing to release nucleic acids for direct detection |
WO2001011826A1 (fr) * | 1999-08-09 | 2001-02-15 | Fujitsu Limited | Dispositif et technique de commande de paquets |
ES2206288T3 (es) | 1999-08-30 | 2004-05-16 | Debiopharm S.A. | Preparacion farmaceutica estable de oxiliplatino para su administracion por via parenteral. |
JP2003519199A (ja) | 1999-12-30 | 2003-06-17 | ノバルティス アクチエンゲゼルシャフト | 遺伝子治療のための新規なコロイド合成ベクター |
WO2001049266A2 (en) | 1999-12-30 | 2001-07-12 | Gwathemy Judith K | Iron chelator delivery system |
CA2397016C (en) * | 2000-01-10 | 2011-03-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of disease |
US6530944B2 (en) | 2000-02-08 | 2003-03-11 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
US7001735B2 (en) | 2000-03-01 | 2006-02-21 | Albert Einstein College Of Medicine Of Yeshiva University | Glucose transporter/sensor protein and uses thereof |
ATE374785T1 (de) | 2000-03-02 | 2007-10-15 | Mitsubishi Pharma Corp | Gpib-gebundenes konstrukt und verwendungen davon |
JP4449147B2 (ja) | 2000-03-22 | 2010-04-14 | 日油株式会社 | ホスファチジルエタノールアミン誘導体の製造方法 |
FR2806727A1 (fr) | 2000-03-23 | 2001-09-28 | Pf Medicament | Molecule d'interet pharmaceutique comprotant en son extremite n-terminale un acide glutamique ou une glutamine sous forme de sel d'addition d'acide fort physiologiquement acceptable |
ES2295149T3 (es) | 2000-04-12 | 2008-04-16 | Liplasome Pharma A/S | Sistemas de suministro de farmacos contra infecciones parasiticas. |
AU2001266272B2 (en) | 2000-05-03 | 2005-09-15 | Medigene Ag | Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
US20030059461A1 (en) | 2000-06-06 | 2003-03-27 | Sibtech, Inc. | Molecular delivery vehicle for delivery of selected compounds to targets |
US20030072794A1 (en) | 2000-06-09 | 2003-04-17 | Teni Boulikas | Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes |
ATE415414T1 (de) | 2000-09-11 | 2008-12-15 | Pasteur Institut | Mitochondrialen membrane permeabilisierung durch hiv-1 vpr und screeningsverfahren |
US20040234588A1 (en) | 2000-09-21 | 2004-11-25 | University Of Georgia Research Foundation, Inc. | Artificial lipoprotein carrier system for bioactive materials |
US20040126431A1 (en) | 2000-10-03 | 2004-07-01 | Frederic Lagarce | Method for preparing microspheres containing a water-soluble substance |
US20030129223A1 (en) * | 2000-10-11 | 2003-07-10 | Targesome, Inc. | Targeted multivalent macromolecules |
EP1209469A1 (en) | 2000-11-22 | 2002-05-29 | Vectron Therapeutics AG | Production and use of a targeted diagnostic system |
WO2002047725A2 (fr) * | 2000-12-12 | 2002-06-20 | Debiopharm S.A. | Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation |
AU2037402A (en) | 2000-12-12 | 2002-06-24 | Australian Inst Marine Science | Assay for paralytic shellfish toxin |
US6897196B1 (en) | 2001-02-07 | 2005-05-24 | The Regents Of The University Of California | pH sensitive lipids based on ortho ester linkers, composition and method |
US6703524B2 (en) | 2001-02-20 | 2004-03-09 | Lkt Laboratories, Inc. | Organoselenium compounds for cancer chemoprevention |
ATE365037T1 (de) | 2001-03-02 | 2007-07-15 | Debiopharm Sa | Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens |
FI113840B (fi) | 2001-03-26 | 2004-06-30 | Ctt Cancer Targeting Tech Oy | Matriisi-metalloproteinaasi-inhibiittorien käyttö liposomien kohdentamisessa |
US20040049022A1 (en) | 2001-04-24 | 2004-03-11 | Nyce Jonathan W. | Composition & methods for treatment and screening |
JP2004535388A (ja) | 2001-04-30 | 2004-11-25 | ターゲティッド ジェネティクス コーポレイション | 脂質含有薬物送達複合体およびそれらの生成方法 |
WO2002089772A1 (en) | 2001-05-09 | 2002-11-14 | Inex Pharmaceuticals Corporation | Anti-angiogenic therapy using liposome-encapsulated chemotherapeutic agents |
US20030108986A1 (en) | 2001-06-21 | 2003-06-12 | Euroscreen, S.A. | Compositions and methods comprising G-protein coupled receptors |
US20040186172A1 (en) | 2001-07-02 | 2004-09-23 | Houssam Ibrahim | Oxaliplatin active substance with a very low content of oxalic acid |
US20030096299A1 (en) | 2001-07-09 | 2003-05-22 | Valerie Wittamer | Natural ligand of G protein coupled receptor ChemR23 and uses thereof |
US6793912B2 (en) | 2001-08-20 | 2004-09-21 | Transave Inc. | Treatment of cancers by inhalation of stable platinum-containing formulations |
DE10144252A1 (de) | 2001-08-31 | 2003-03-27 | Fraunhofer Ges Forschung | Nanopartikel mit daran immobilisiertem biologisch aktivem TNF |
WO2003028640A2 (en) | 2001-10-03 | 2003-04-10 | Vanderbilt University | In vivo panning for ligands to radiation-induced molecules |
US7101985B2 (en) | 2001-11-20 | 2006-09-05 | Baylor College Of Medicine | Methods and compositions in checkpoint signaling |
JP4468617B2 (ja) | 2001-12-04 | 2010-05-26 | デビオファーム エス.アー. | 抗癌剤の併用投与方法及び併用可能な抗癌剤 |
US6476068B1 (en) | 2001-12-06 | 2002-11-05 | Pharmacia Italia, S.P.A. | Platinum derivative pharmaceutical formulations |
JP4360915B2 (ja) | 2002-01-07 | 2009-11-11 | ユーロスクリーン・ソシエテ・アノニム | Gタンパク質共役受容体gpr43のリガンドおよびその使用 |
US20030220284A1 (en) | 2002-02-22 | 2003-11-27 | Patricia Yotnda | Delivery of adenoviral DNA in a liposomal formulation for treatment of disease |
CN1649902B (zh) | 2002-03-01 | 2011-04-13 | 免疫医疗公司 | 内在化抗-cd74抗体和使用方法 |
US20050100963A1 (en) | 2002-03-01 | 2005-05-12 | Dyax Corporation | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
WO2003082907A1 (en) | 2002-03-29 | 2003-10-09 | Euroscreen Sa | Ligands for g protein coupled receptor gpr7 and uses thereof |
CA2391438A1 (en) | 2002-05-01 | 2003-11-01 | Procyon Biopharma Inc. | Psp94 diagnostic reagents and assays |
US20030228285A1 (en) | 2002-05-03 | 2003-12-11 | Mien-Chie Hung | Bipartite T-cell factor (Tcf)-responsive promoter |
US7460960B2 (en) | 2002-05-10 | 2008-12-02 | Epitome Biosystems, Inc. | Proteome epitope tags and methods of use thereof in protein modification analysis |
JP3415131B1 (ja) | 2002-06-03 | 2003-06-09 | メビオファーム株式会社 | リポソーム製剤 |
FR2840236B1 (fr) | 2002-06-03 | 2005-02-04 | Inst Francais Du Petrole | Membrane zeolithique de faible epaisseur, sa preparation et son utilisation en separation |
US20040022842A1 (en) | 2002-06-03 | 2004-02-05 | Mebiopharm Co., Ltd. | Liposome preparations containing oxaliplatin |
WO2003103723A2 (en) | 2002-06-07 | 2003-12-18 | Immunomedics, Inc. | Neutrophil imaging methods in cyctic fibrosis |
EP1521775B1 (en) | 2002-06-14 | 2015-09-09 | Immunomedics, Inc. | Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer |
WO2003106495A2 (en) | 2002-06-14 | 2003-12-24 | Immunomedics, Inc. | MONOCLONAL ANTIBODY hPAM4 |
US6790632B2 (en) | 2002-06-17 | 2004-09-14 | Stephen Eliot Zweig | Membrane receptor reagent and assay |
ATE485031T1 (de) | 2002-06-28 | 2010-11-15 | Protiva Biotherapeutics Inc | Verfahren und vorrichtung zur herstellung von liposomen |
CA2494310A1 (en) | 2002-08-01 | 2004-02-12 | Immunomedics, Inc. | Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
US20040132652A1 (en) | 2002-08-30 | 2004-07-08 | Shire Biochem Inc. | Pharmaceutical compositions |
WO2004045519A2 (en) | 2002-11-14 | 2004-06-03 | Kirk Sperber | Induction of apoptosis by hiv-1 infected monocytic cells |
WO2004045583A1 (ja) | 2002-11-15 | 2004-06-03 | Nipro Corporation | リポソーム |
JPWO2004071518A1 (ja) | 2003-02-17 | 2006-06-01 | メビオファーム株式会社 | 癌治療薬 |
WO2004094613A2 (en) | 2003-04-22 | 2004-11-04 | Ibc Pharmaceuticals | Polyvalent protein complex |
CA2529027C (en) | 2003-06-13 | 2013-09-10 | Immunomedics, Inc. | D-amino acid peptides |
EP1648512A4 (en) | 2003-07-31 | 2009-01-21 | Immunomedics Inc | ANTI-CD19 ANTIBODIES |
JP2005154282A (ja) | 2003-11-20 | 2005-06-16 | Mebiopharm Co Ltd | ガス封入リポソームの製造法 |
US7582430B2 (en) * | 2004-01-20 | 2009-09-01 | United States Of America As Represented By The Secretary Of The Army | Immunoliposome-nucleic acid amplification (ILNAA) assay |
US7212869B2 (en) * | 2004-02-04 | 2007-05-01 | Medtronic, Inc. | Lead retention means |
EP1579850A3 (en) | 2004-03-15 | 2009-12-16 | Nipro Corporation | A pharmaceutical composition containing liposomes for treating a cancer |
JP2006248978A (ja) | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | 新規なリポソーム製剤 |
WO2008030818A2 (en) | 2006-09-05 | 2008-03-13 | Mebiopharm Co., Ltd. | Novel liposome compositions |
JP5345792B2 (ja) | 2008-02-19 | 2013-11-20 | テイ・エス テック株式会社 | 車両用格納シート |
JP5331648B2 (ja) | 2009-10-22 | 2013-10-30 | 株式会社日立製作所 | 微粉炭ボイラの改造方法 |
-
2005
- 2005-03-10 JP JP2005067469A patent/JP2006248978A/ja active Pending
-
2006
- 2006-03-08 EP EP06737793.7A patent/EP1863448B1/en active Active
- 2006-03-08 AU AU2006223329A patent/AU2006223329B2/en not_active Ceased
- 2006-03-08 JP JP2008500977A patent/JP5438317B2/ja not_active Expired - Fee Related
- 2006-03-08 BR BRPI0608297-1A patent/BRPI0608297A2/pt not_active IP Right Cessation
- 2006-03-08 NZ NZ561569A patent/NZ561569A/en not_active IP Right Cessation
- 2006-03-08 KR KR1020077023219A patent/KR101352490B1/ko not_active IP Right Cessation
- 2006-03-08 ZA ZA200708600A patent/ZA200708600B/xx unknown
- 2006-03-08 WO PCT/US2006/008650 patent/WO2006099169A2/en active Application Filing
- 2006-03-08 HU HUE06737793A patent/HUE024290T2/en unknown
- 2006-03-08 CN CN2006800159670A patent/CN101170995B/zh not_active Expired - Fee Related
- 2006-03-08 MX MX2007010996A patent/MX2007010996A/es active IP Right Grant
- 2006-03-08 DK DK06737793.7T patent/DK1863448T3/en active
- 2006-03-08 PL PL06737793T patent/PL1863448T3/pl unknown
- 2006-03-08 PT PT67377937T patent/PT1863448E/pt unknown
- 2006-03-08 RU RU2007137492/15A patent/RU2454229C2/ru not_active IP Right Cessation
- 2006-03-08 SI SI200631892T patent/SI1863448T1/sl unknown
- 2006-03-08 CA CA002600446A patent/CA2600446A1/en not_active Abandoned
- 2006-03-08 ES ES06737793.7T patent/ES2529453T3/es active Active
- 2006-03-08 US US11/371,586 patent/US7829113B2/en not_active Expired - Fee Related
-
2007
- 2007-10-09 NO NO20075136A patent/NO20075136L/no not_active Application Discontinuation
-
2008
- 2008-05-28 HK HK08105936.8A patent/HK1111625A1/xx not_active IP Right Cessation
-
2010
- 2010-09-27 US US12/891,568 patent/US8758810B2/en not_active Expired - Fee Related
-
2014
- 2014-05-09 US US14/274,377 patent/US20140363491A1/en not_active Abandoned
-
2015
- 2015-02-06 CY CY20151100123T patent/CY1116075T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL1863448T3 (pl) | 2015-05-29 |
CY1116075T1 (el) | 2017-02-08 |
KR101352490B1 (ko) | 2014-02-04 |
RU2007137492A (ru) | 2009-04-20 |
NO20075136L (no) | 2007-12-07 |
NZ561569A (en) | 2011-03-31 |
WO2006099169A2 (en) | 2006-09-21 |
WO2006099169A3 (en) | 2007-02-22 |
RU2454229C2 (ru) | 2012-06-27 |
US20140363491A1 (en) | 2014-12-11 |
SI1863448T1 (sl) | 2015-03-31 |
JP2008538105A (ja) | 2008-10-09 |
BRPI0608297A2 (pt) | 2009-12-08 |
ES2529453T3 (es) | 2015-02-20 |
KR20080002819A (ko) | 2008-01-04 |
CN101170995A (zh) | 2008-04-30 |
EP1863448B1 (en) | 2014-11-26 |
AU2006223329A1 (en) | 2006-09-21 |
EP1863448A2 (en) | 2007-12-12 |
MX2007010996A (es) | 2007-11-07 |
DK1863448T3 (en) | 2015-02-16 |
US20110081404A1 (en) | 2011-04-07 |
US20060222696A1 (en) | 2006-10-05 |
JP2006248978A (ja) | 2006-09-21 |
US8758810B2 (en) | 2014-06-24 |
CA2600446A1 (en) | 2006-09-21 |
PT1863448E (pt) | 2015-02-10 |
CN101170995B (zh) | 2013-01-16 |
AU2006223329B2 (en) | 2011-11-17 |
US7829113B2 (en) | 2010-11-09 |
HUE024290T2 (en) | 2016-01-28 |
JP5438317B2 (ja) | 2014-03-12 |
HK1111625A1 (en) | 2008-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200708600B (en) | Novel liposome compositions | |
IL229521A0 (en) | A new preparation | |
IL185901A0 (en) | Novel composition | |
AP2008004547A0 (en) | Petsticidal compositions | |
GB0503337D0 (en) | Compositions | |
IL186721A0 (en) | Bioenhanced compositions | |
EP1930012A4 (en) | COMPOSITION CONTAINING A CELLO-OLIGOSACCHARIDE | |
GB0526283D0 (en) | Compositions | |
EP1865042A4 (en) | ANTI-FREEZE COMPOSITION | |
GB0501365D0 (en) | Compositions | |
IL186093A0 (en) | Lignan-containing compositions | |
GB0519164D0 (en) | Composition | |
GB0524128D0 (en) | Compositions | |
EP1847249A4 (en) | hair dye | |
GB0502479D0 (en) | Novel compositions | |
GB0502475D0 (en) | Novel compositions | |
ZA200709913B (en) | Bioenhanced compositions | |
EP1864573A4 (en) | AGRICULTURAL CHEMICAL COMPOSITION | |
GB0525321D0 (en) | Novel compositions | |
GB0505760D0 (en) | Novel composition | |
GB0526282D0 (en) | Compositions | |
GB0524803D0 (en) | Novel compositions | |
GB0513367D0 (en) | Novel composition | |
HK1101657A2 (en) | Novel composition | |
GB0501364D0 (en) | Compositions |